HighPoint Advisor Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,479
Closed -$391K 696
2025
Q2
$391K Buy
4,479
+283
+7% +$22.2K 0.02% 441
2025
Q1
$299K Sell
4,196
-749
-15% -$61.1K 0.02% 491
2024
Q4
$427K Buy
+4,945
New +$366K 0.02% 414
2024
Q3
Sell
-3,448
Closed -$240K 711
2024
Q2
$240K Sell
3,448
-173
-5% -$21.9K 0.01% 540
2024
Q1
$452K Buy
3,621
+15
+0.4% +$1.89K 0.03% 367
2023
Q4
$505K Buy
+3,606
New +$368K 0.04% 353
2022
Q2
$263K Buy
+3,480
New +$318K 0.03% 420
2021
Q3
$406K Buy
2,968
+188
+7% +$23.7K 0.04% 346
2021
Q2
$297K Buy
2,780
+516
+23% +$49.6K 0.03% 398
2021
Q1
$217K Hold
2,264
0.03% 440
2020
Q4
$227K Sell
2,264
-6,128
-73% -$547K 0.03% 405
2020
Q3
$745K Buy
8,392
+596
+8% +$62.3K 0.13% 131
2020
Q2
$780K Sell
7,796
-316
-4% -$28.3K 0.17% 113
2020
Q1
$674K Buy
+8,112
New +$505K 0.16% 110

Other funds holding DXCM